| |
| |
SPOT ON
|
| |
Globalisation of the clinical research: export of risks
|
| |
| |
NEW ON THE MARKET
|
| |
Ranolazin (RANEXA) for angina pectoris
|
| |
| |
THERAPY FROM A CRITICAL VIEWPOINT
|
| |
Mass vaccination with pneumococcal conjugate vaccine PREVENAR - first data from Europe
|
| |
| |
a-t READER'S QUESTIONS AND COMMENTS
|
| |
Ginkgo biloba useful for dementia?
|
| |
| |
CURRENT ADR NETWORK REPORT
|
| |
 |
Nightmares on CSE inhibitors
|
| |
| |
IN BRIEF
|
| |
Prasugrel, Lilly and FDA - exclusion of an expert following a phone call
|
| |
| |
SIDE EFFECTS
|
| |
Long term metoclopramide: tardive dyskinesia
Guillain-Barré syndrome after HPV-vaccination
Tibolone (LIVIELLA) increases the risk of breast cancer recurrence
Efalizumab (RAPTIVA): suspension of marketing authorisation recommended
|
| |